Aimovig *
Pharmacy Only: Prescription

  • Company:

    Novartis Ireland Limited
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Updated on 21 December 2021

File name

Aimovig-REGPIL PEN PF21-0324 Clean_Dec 2021_1640099319.pdf

Reasons for updating

  • Change to section 5 - how to store or dispose

Updated on 21 December 2021

File name

Aimovig_REGSPC PF 21-0324 _Dec 2021_Clean_1640085794.pdf

Reasons for updating

  • Change to section 6.3 - Shelf life

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 14 July 2021

File name

Aimovig_REG PIL_PF21-0118_06.05.2021_clean_Nürnberg _1626246997.pdf

Reasons for updating

  • Change to section 5 - how to store or dispose

Updated on 23 June 2021

File name

Aimovig_REG SPC_PF21-0118_06.05.2021_clean_1624445990.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 03 September 2020

File name

Aimovig REGSPC PF 20-0014 Clean_August 2020_1599144674.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 03 September 2020

File name

Aimovig REGPIL PF 20-0014 Clean 08.2020_1599144592.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 20 February 2020

File name

Aimovig REGSPC PF 19-0192_Clean Feb 2020 medicines.ie_1582207616.pdf

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 18 February 2020

File name

Aimovig 70mg 140mg REGPIL PF19-0192 MT and IE Clean 02.2020 IPHA_1582030561.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 18 February 2020

File name

Aimovig REGSPC PF 19-0192_Clean Feb 2020_1582023772.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 18 September 2019

File name

Aimovig clean Leaflet 70mg and 140mg IPHA_1568803160.pdf

Reasons for updating

  • Correction of spelling/typing errors

Updated on 13 September 2019

File name

Aimovig_140mg-ml_70mg_REGSPC PF19-0186_August 2019_Clean updated_1568376159.pdf

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 02 September 2019

File name

Aimovig_Clean_Leaflet 70mg and 140mg R89 August 2019 IPHA_1567428935.pdf

Reasons for updating

  • Change to section 4 - possible side effects

Updated on 02 September 2019

File name

Aimovig_140mg-ml_70mg_REGSPC PF19-0186_August 2019_Clean_1567427858.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 24 May 2019

File name

Aimovig_140mg-ml_70mg_Soln_In REGPIL_26-Apr-19_English_Clean_1558706177.pdf

Reasons for updating

  • Introduction of new strength

Updated on 09 May 2019

File name

Aimovig_140mg-ml_70mg_Soln_Inj_REGSPC PF 19-0098_April 2019_Clean_1557398769.pdf

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 04 December 2018

File name

Aimovig 70mg SmPC updated 04.12.2018_1543942490.pdf

Reasons for updating

  • Change to section 3 - Pharmaceutical form

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 05 November 2018

File name

Aimovig 70mg 1018970_R89_p1_LFT_X-4 RA approved 22.08.2018_1541418815.pdf

Reasons for updating

  • New PIL for new product

Updated on 05 November 2018

File name

Aimovig 70mg SmPC_1541418748.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)